Epicardial substrate and outcome with epicardial ablation of ventricular tachycardia in arrhythmogenic right ventricular cardiomyopathy/dysplasia

Circulation

Volumn 120, Issue 5, 2009, Pages 366-375

  Garcia, Fermin C ^a   Bazan, Victor ^a   Zado, Erica S ^a   Ren, Jian Fang ^a   Marchlinski, Francis E ^a,b  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^b 9 Founders Pavilion ^*  (United States)

Author keywords

Ablation; Arrhythmogenic right ventricular cardiomyopathy dysplasia; Cardiomyopathy; Epicardium; Ventricular tachycardia

Indexed keywords

AMIODARONE; FLECAINIDE; LIDOCAINE; MEXILETINE; PROCAINAMIDE; PROPAFENONE; QUINIDINE; SOTALOL;

ADOLESCENT; ADULT; AGED; ARTICLE; CATHETER ABLATION; CLINICAL ARTICLE; CONTROLLED STUDY; ELECTRIC POTENTIAL; ELECTROPHYSIOLOGY; ENDOCARDIUM; EPICARDIUM MAPPING; FEMALE; HEART RIGHT VENTRICLE DYSPLASIA; HEART VENTRICLE TACHYCARDIA; HEART VENTRICLE WALL; HUMAN; MALE; PRIORITY JOURNAL; SINUS RHYTHM; SURGICAL APPROACH; SURGICAL TECHNIQUE; TREATMENT FAILURE; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA; CATHETER ABLATION; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HEART VENTRICLES; HUMANS; MALE; MIDDLE AGED; PERICARDIUM; PREOPERATIVE CARE; REOPERATION; TACHYCARDIA, VENTRICULAR; TREATMENT OUTCOME; YOUNG ADULT;

EID: 68249104191     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.108.834903     Document Type: Article

References (15)

1. Marchlinski FE, Zado E, Dixit S, Gerstenfeld E, Callans DJ, Hsia H, Lin D, Nayak H, Russo A, Pulliam W. Electroanatomic substrate and outcome of catheter ablative therapy for ventricular tachycardia in the setting of right ventricular cardiomyopathy. Circulation. 2004;110:2293-2298.
2. Ellison KE, Friedman PL, Ganz LI, Stevenson WG. Entrainment mapping and radiofrequency catheter ablation of ventricular tachycardia in right ventricular dysplasia. J Am Col Cardiol. 1988;32:724-728.
3. Dalal D, Jain R, Tandri H, Dong J, Eid SM, Prakasa K, Tichnell C, James C, Abraham T, Russell SD, Sinha S, Judge DP, Bluemke DA, Marine JE, Calkins H. Long-term efficacy of catheter ablation of ventricular tachycardia in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy. J Am Col Cardiol. 2007;50:432-440.
4. Nogami A, Sugiyasu A, Tada H, Kurosaki K, Sakamaki M, Kowase S, Oginosawa Y, Kubotz S, Usi T, Naito S. Changes in the isolated delayed component as an endpoint of catheter ablation in arrhythmogenic right ventricular cardiomyopathy: predictor of long-term success. J Cardiovasc Electrophysiol. 2008;19:681-688.
5. Yao Y, Zhang S, He DS, Zhang K, Hua W, Chu J, Pu J, Chen K, Wang F, Chen X. Radiofrequency ablation of the ventricular tachycardia with arrhythmogenic right ventricular cardiomyopathy using non-contact mapping. Pacing Clin Electrophysiol. 2007;30:526-533.
6. Basso C, Thiene G, Corrado D, Angelini A, Nava A, Valente M. Arrhythmogenic right ventricular cardiomyopathy: dysplasia, dystrophy, or myocarditis? Circulation. 1996;94:983-991.
7. Lobo FV, Heggtveit HA, Butany J, Silver MD, Edwards JE. Right ventricular dysplasia: morphological findings in 13 cases. Can J Cardiol. 1992;8:261-268.
8. Tabib A, Loire R, Chalabreysse L, Meyronnet D, Miras A, Malicier D, Thivolet F, Chevalier P, Bouvagnet P. Circumstances of death and gross and microscopic observations in a series of 200 cases of sudden death associated with arrhythmogenic right ventricular cardiomyopathy and/or dysplasia. Circulation. 2003;108:3000-3005.
9. McKenna WJ, Thiene G, Nava A, Fontaliran F, Blomstrom-Lundqvist C, Fontaine G, Camerini F. Diagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy: Task Force of the Working Group for Myocardial and Pericardial Disease of the European Society of Cardiology and of the Scientific Council on Cardiomyopathies of the International Society and Federation of Cardiology. Br Heart J. 1994;71:215-218.
10. Sosa E, Scanavacca M, d'Avila A, Pilleggi F. A new technique to perform epicardial mapping in the electrophysiology laboratory. J Cardiovasc Electrophysiol. 1996;7:531-539.
11. Marchlinski FE, Callans DJ, Gottlieb CD, Zado E. Linear ablation lesions for control of unmappable ventricular tachycardia in patients with ischemic and nonischemic cardiomyopathy. Circulation. 2000;101:1288-1296.
12. Cano O, Bala R, Riley MP, Hutchinson MD, Garcia FC, Lin D, Dixit S, Gerstenfeld EP, Callans DJ, Marchlinski FE. Electrogram characteristics of the epicardial ventricular tachycardia substrate in nonischemic cardiomyopathy. Heart Rhythm. 2008;5:S173. Abstract.
13. Fontaine G, Frank R, Tonet JL, Guiraudon G, Cabrol C, Chomette G, Grosgogeat Y. Arrhythmogenic right ventricular dysplasia: a clinical model for the study of chronic ventricular tachycardia. Jpn Circ J. 1984;48:515-538.
14. Bazan V, Bala R, Garcia FC, Sussman JS, Gerstenfeld EP, Dixit S, Callans DJ, Zado E, Marchlinski FE. Twelve-lead ECG features to identify ventricular tachycardia arising from the epicardial right ventricle. Heart Rhythm. 2006;3:1132-1139.
15. Awad MM, Calkins H, Judge DP. Mechanisms of disease: molecular genetics of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Nat Clin Pract Cardiovasc Med. 2008;5:258-267.